
|Videos|June 30, 2023
Systemic Therapy in Malignant PEComas
Andrew Wagner, MD, PhD, details his typical treatment approach for systemic therapy in patients with malignant PEComa.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Poll Results Reveal Readers’ Top Abstracts at ASH 2025
2
FDA Approves Liso-Cel as First CAR T-Cell Therapy for Marginal Zone Lymphoma
3
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
4
Lurbinectedin Contributes to Maintenance of Response in ES-SCLC
5








































